Michael Lishner
About
In The Last Decade
Michael Lishner
234 papers receiving 5.8k citations
Peers
Comparison fields: 5 of 144
- Oncology 2.3k
- Molecular Biology 1.2k
- Epidemiology 1.1k
- Cardiology and Cardiovascular Medicine 808
- Hematology 770
Countries citing papers authored by Michael Lishner
This map shows the geographic impact of Michael Lishner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Lishner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Lishner more than expected).
Fields of papers citing papers by Michael Lishner
This network shows the impact of papers produced by Michael Lishner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Lishner. The network helps show where Michael Lishner may publish in the future.
Co-authorship network of co-authors of Michael Lishner
This figure shows the co-authorship network connecting the top 25 collaborators of Michael Lishner. A scholar is included among the top collaborators of Michael Lishner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Lishner. Michael Lishner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 21 | |
| 2 | 0 | |
| 3 | 3 | |
| 4 | 17 | |
| 5 | [THE EFFECT OF PREGNANCY ON BREAST CANCER]. | 1 |
| 6 | 4 | |
| 7 | 16 | |
| 8 | 11 | |
| 9 | Cryptococcal meningitis in chronic lymphocytic leukemia patients. | 13 |
| 10 | Should bone marrow examination be routinely performed for the diagnosis of monoclonal gammopathy of undetermined significance? | 1 |
| 11 | 37 | |
| 12 | 7 | |
| 13 | 63 | |
| 14 | 2 | |
| 15 | 26 | |
| 16 | 6 | |
| 17 | 31 | |
| 18 | 20 | |
| 19 | 9 | |
| 20 | 3 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.